Enhanced Safety Profile of Ocrelizumab Over Rituximab in Multiple Sclerosis Treatment (P8-1.006)
Compare long-term safety profiles of ocrelizumab and rituximab in multiple sclerosis (MS) patients using real-world data from multiple specialized MS centers.
Authors
- Sergio E. Baranzini (ORCID: https://orcid.org/0000-0003-0067-194X)
- Gabriel Cerono (ORCID: https://orcid.org/0000-0002-9411-2526)
- Bruce Cree
- Stephen L. Hauser
Institutions
- Multiple Sclerosis Foundation (US)
- Universidad Católica de Santa Fe (AR)
- Center for Neurosciences (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210723
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00